Medifast will announce its financial results for the third quarter ended September 30, 2026, on Monday, October 26, 2026, before market open. The metabolic health and wellness company will host a conference call to discuss the results and provide additional details.

Conference Call Details

The earnings call is scheduled to begin at 8:30 am ET on October 26, 2026. Company participants include Nick Johnson, Chief Executive Officer, and Jim Maloney, Chief Financial Officer.

The call will be broadcast live over the Internet via the Investor Relations section of the company's website. Listeners may also join via telephone by dialing (201) 389-0879.

Playback Information

A telephonic playback of the conference call will be available from 12:30 pm ET on October 26, 2026, through November 2, 2026. Participants can access the playback by dialing (412) 317-6671 and entering the access code 13762848. The webcast archive will remain available online through January 26, 2027.

About Medifast

Medifast is a metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy. The company’s holistic approach integrates science-backed plans and products, personal 1:1 coaching, a supportive community, and behavioral science support to develop healthy habits.

Medifast has introduced Metabolic Synchronization, a breakthrough science targeting metabolic dysfunction through a system focused on fat loss, lean mass preservation, and long-term health. Backed by more than 45 years of clinical heritage, the company continues to advance its mission of lifelong transformation through metabolic science.

Medifast (NYSE: MED) announced the launch of the Medifast Metabolic Health Institute to centralize its clinical research and evidence-based education efforts. The initiative consolidates the company’s scientific resources under a single body.

The institute builds on Medifast’s 45 years of clinical research. It follows the July launch of Trilivy, which replaced OPTAVIA as the company’s consumer brand. This rebranding reflects an evolved focus on metabolic health.

Research Foundation

The institute is anchored by a substantial body of existing scientific work. Medifast cites more than 100 peer-reviewed presentations and publications. This includes:

• More than 40 peer-reviewed scientific journal publications
• 18 randomized controlled trials
• More than 30 scientific research studies and analyses

This data underpins Metabolic Synchronization, the science behind Trilivy’s comprehensive metabolic health system. The institute aims to strengthen the substantiation behind this system.

Leadership and Standards

Dr. Wayne Scott Andersen serves as MMHI Distinguished Fellow. The Medifast Scientific Advisory Board, formed in 2008, guides the institute’s work. Day-to-day operations are led by the Scientific & Clinical Affairs team.

The institute also sets standards for Trilivy’s Coach Certification. Developed by internal experts, the certification ensures independent coaches possess foundational knowledge in metabolic health. It is completed annually to maintain professional credibility.

Recent Activity

Medifast’s Scientific & Clinical Affairs team recently presented four research posters at the annual American Society for Nutrition conference. The posters highlighted emerging research on obesity, metabolic health, healthy aging, and nutrition.